171 related articles for article (PubMed ID: 34048735)
21. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
Digits JA; Hedstrom L
Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
[TBL] [Abstract][Full Text] [Related]
22. Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation.
Zimmermann AG; Gu JJ; Laliberté J; Mitchell BS
Prog Nucleic Acid Res Mol Biol; 1998; 61():181-209. PubMed ID: 9752721
[TBL] [Abstract][Full Text] [Related]
23. Integrative analysis of circadian transcriptome and metabolic network reveals the role of de novo purine synthesis in circadian control of cell cycle.
Li Y; Li G; Görling B; Luy B; Du J; Yan J
PLoS Comput Biol; 2015 Feb; 11(2):e1004086. PubMed ID: 25714999
[TBL] [Abstract][Full Text] [Related]
24. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
Jayaram HN; Cooney DA; Grusch M; Krupitza G
Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
[TBL] [Abstract][Full Text] [Related]
25. GTP metabolic reprogramming by IMPDH2: unlocking cancer cells' fuelling mechanism.
Kofuji S; Sasaki AT
J Biochem; 2020 Oct; 168(4):319-328. PubMed ID: 32702086
[TBL] [Abstract][Full Text] [Related]
26. Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones.
Barnes BJ; Eakin AE; Izydore RA; Hall IH
Biochemistry; 2000 Nov; 39(45):13641-50. PubMed ID: 11076502
[TBL] [Abstract][Full Text] [Related]
27. Neurodevelopmental disorder mutations in the purine biosynthetic enzyme IMPDH2 disrupt its allosteric regulation.
O'Neill AG; Burrell AL; Zech M; Elpeleg O; Harel T; Edvardson S; Mor-Shaked H; Rippert AL; Nomakuchi T; Izumi K; Kollman JM
J Biol Chem; 2023 Aug; 299(8):105012. PubMed ID: 37414152
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
McMillan FM; Cahoon M; White A; Hedstrom L; Petsko GA; Ringe D
Biochemistry; 2000 Apr; 39(15):4533-42. PubMed ID: 10758003
[TBL] [Abstract][Full Text] [Related]
29. Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression.
Dayton JS; Lindsten T; Thompson CB; Mitchell BS
J Immunol; 1994 Feb; 152(3):984-91. PubMed ID: 7905505
[TBL] [Abstract][Full Text] [Related]
30. Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation.
Johnson MC; Kollman JM
Elife; 2020 Jan; 9():. PubMed ID: 31999252
[TBL] [Abstract][Full Text] [Related]
31. Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases.
Buey RM; Ledesma-Amaro R; Velázquez-Campoy A; Balsera M; Chagoyen M; de Pereda JM; Revuelta JL
Nat Commun; 2015 Nov; 6():8923. PubMed ID: 26558346
[TBL] [Abstract][Full Text] [Related]
32. Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells.
Metz S; Holland S; Johnson L; Espling E; Rabaglia M; Segu V; Brockenbrough JS; Tran PO
Endocrinology; 2001 Jan; 142(1):193-204. PubMed ID: 11145582
[TBL] [Abstract][Full Text] [Related]
33. IMPDH1 retinal variants control filament architecture to tune allosteric regulation.
Burrell AL; Nie C; Said M; Simonet JC; Fernández-Justel D; Johnson MC; Quispe J; Buey RM; Peterson JR; Kollman JM
Nat Struct Mol Biol; 2022 Jan; 29(1):47-58. PubMed ID: 35013599
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
[TBL] [Abstract][Full Text] [Related]
35. Increased riboflavin production by manipulation of inosine 5'-monophosphate dehydrogenase in Ashbya gossypii.
Buey RM; Ledesma-Amaro R; Balsera M; de Pereda JM; Revuelta JL
Appl Microbiol Biotechnol; 2015 Nov; 99(22):9577-89. PubMed ID: 26150243
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
37. Expression, purification, and characterization of inosine 5'-monophosphate dehydrogenase from Borrelia burgdorferi.
Zhou X; Cahoon M; Rosa P; Hedstrom L
J Biol Chem; 1997 Aug; 272(35):21977-81. PubMed ID: 9268334
[TBL] [Abstract][Full Text] [Related]
38. A regulatory role of the Bateman domain of IMP dehydrogenase in adenylate nucleotide biosynthesis.
Pimkin M; Pimkina J; Markham GD
J Biol Chem; 2009 Mar; 284(12):7960-9. PubMed ID: 19153081
[TBL] [Abstract][Full Text] [Related]
39. Inosine 5'-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo.
McLean JE; Hamaguchi N; Belenky P; Mortimer SE; Stanton M; Hedstrom L
Biochem J; 2004 Apr; 379(Pt 2):243-51. PubMed ID: 14766016
[TBL] [Abstract][Full Text] [Related]
40. Immune Response-Dependent Assembly of IMP Dehydrogenase Filaments.
Calise SJ; Abboud G; Kasahara H; Morel L; Chan EKL
Front Immunol; 2018; 9():2789. PubMed ID: 30555474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]